Valuation: Takeda Pharmaceutical Company Limited

Market Cap 9,49400Cr 6.09TCr 5.31TCr 5.02TCr 4.56TCr 8.53TCr 5,83600Cr 8.57TCr 60TCr 23TCr 2,96600Cr 23TCr 22TCr P/E 2027 *
47.1x
P/E 2028 * 29.9x
Enterprise Value 13,40100Cr 8.6TCr 7.49TCr 7.09TCr 6.44TCr 12TCr 8,23700Cr 12TCr 84TCr 33TCr 4,18600Cr 32TCr 32TCr EV / Sales 2027 *
2.85x
EV / Sales 2028 * 2.76x
Free-Float
99.26%
Yield 2027 *
3.44%
Yield 2028 * 3.5%
1 day+4.14%
1 week+6.63%
Current month+7.40%
1 month+9.32%
3 months+23.54%
6 months+5.44%
Current year+27.06%
1 week 31.28
Extreme 31.28
33.53
1 month 29.97
Extreme 29.97
33.53
Current year 25.46
Extreme 25.46
33.53
1 year 22.45
Extreme 22.45
33.53
3 years 22.45
Extreme 22.45
33.53
5 years 22.45
Extreme 22.45
33.53
10 years 22.45
Extreme 22.45
50
Manager TitleAgeSince
Chief Executive Officer 56 01/01/2025
Director of Finance/CFO 48 01/04/2024
Chief Tech/Sci/R&D Officer 47 01/02/2022
Director TitleAgeSince
Director/Board Member 60 01/06/2015
Director/Board Member 73 01/01/2019
Director/Board Member 48 01/06/2024
Change 5-day change 1-year change 3-year change Capi.($)
+3.29%+6.63% - - 6.02TCr
+1.28%+2.62%+51.61%+101.73% 1,01400Cr
+1.10%+1.45%+52.49%+66.32% 64TCr
+0.58%+3.54%+19.57%+71.51% 46TCr
-0.36%+3.88%+39.78%+38.21% 35TCr
+1.52%+3.90%+19.76%+25.75% 27TCr
+2.41%+6.68%+9.54%+13.60% 25TCr
+0.91%-0.70%+38.25%+44.32% 20TCr
+2.48%-3.31%-22.21%-58.09% 19TCr
+2.17%+4.20%+34.41%+99.54% 18TCr
Average +1.53%+0.96%+27.02%+44.77% 39.63TCr
Weighted average by Cap. +1.12%+1.41%+35.58%+61.48%

Financials

2027 *2028 *
Net sales 4,70100Cr 3.02TCr 2.63TCr 2.49TCr 2.26TCr 4.22TCr 2,88900Cr 4.24TCr 30TCr 11TCr 1,46800Cr 11TCr 11TCr 4,78200Cr 3.07TCr 2.67TCr 2.53TCr 2.3TCr 4.29TCr 2,93900Cr 4.32TCr 30TCr 12TCr 1,49400Cr 12TCr 11TCr
Net income 20TCr 126.11Cr 109.84Cr 103.96Cr 94Cr 176.46Cr 12TCr 177.33Cr 1.24TCr 478.8Cr 6.14TCr 473.75Cr 463.21Cr 32TCr 207.13Cr 180.41Cr 170.74Cr 155.13Cr 289.81Cr 20TCr 291.24Cr 2.03TCr 786.38Cr 10TCr 778.09Cr 760.78Cr
Net Debt 3,90700Cr 2.51TCr 2.18TCr 2.07TCr 1.88TCr 3.51TCr 2,40100Cr 3.53TCr 25TCr 9.52TCr 1,22000Cr 9.42TCr 9.21TCr 3,70200Cr 2.38TCr 2.07TCr 1.96TCr 1.78TCr 3.32TCr 2,27600Cr 3.34TCr 23TCr 9.02TCr 1,15600Cr 8.93TCr 8.73TCr
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
18/26/18 32.96 +3.29% 150
16/26/16 €31.91 -1.21% 0
15/26/15 €32.30 +0.06% 200
14/26/14 €32.28 +3.20% 225
11/26/11 €31.28 -0.22% 100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
5,946.00JPY
Average target price
6,622.06JPY
Spread / Average Target
+11.37%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!